Skip to main content

Month: August 2024

embecta to Participate in Investor Events

PARSIPPANY, N.J., Aug. 22, 2024 (GLOBE NEWSWIRE) — Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced that management will participate in the following investor events: 2024 Wells Fargo Healthcare Conference•  Management will host one-on-one investor meetings on Wednesday, September 4, 2024, at the Encore Boston Harbor Hotel in Boston.2024 Morgan Stanley 22nd Annual Global Healthcare Conference•  Management will host a fireside session on Thursday, September 5, 2024, at 2:35 p.m. Eastern Time (ET) at the Marriott Marquis in New York. Audio webcasts of the presentations will be accessible under the “News & Events” section of the Company’s investor relations website at https://investors.embecta.com.About embecta embecta is a global...

Continue reading

Northview Residential REIT Announces August Distribution

Not for distribution to U.S. newswire services or for dissemination in the United States. CALGARY, Alberta, Aug. 22, 2024 (GLOBE NEWSWIRE) — Northview Residential REIT (the “REIT”) today announced its August 2024 cash distribution amounts on its outstanding Class A Units, Class C Units and Class F Units (collectively, the “Units”) in the amount of C$0.091146 per Unit (C$1.09 per Unit on an annualized basis). The distribution will be payable on September 16, 2024 to holders of Units of record at August 31, 2024. About Northview Residential REIT The REIT is a publicly traded real estate investment trust established pursuant to a declaration of trust under the laws of the Province of Ontario for the primary purpose of indirectly acquiring, owning and operating a portfolio of income producing rental properties in secondary markets...

Continue reading

Inventronics Announces 2024 Q2 Financial Results

CALGARY, Alberta, Aug. 22, 2024 (GLOBE NEWSWIRE) — Inventronics Limited (“Inventronics” or the “Corporation”) (IVX:TSX Venture), a designer and manufacturer of enclosures for the telecommunications, cable, electric distribution, energy, and other industries in North America, today announced its unaudited 2024 Q2 financial results. For the three months ended June 30, 2024, Inventronics reported net earnings of $141,000, or 2.9 cents per share, on revenue of $1,945,000 compared to net earnings of $346,000, or 7.1 cents per share, on revenue of $3,103,000 for the three months ended June 30, 2023. For the six months ended June 30, 2024, Inventronics reported net earnings of $149,000, or 3.1 cents per share, on revenue of $3,377,000 compared to net earnings of $671,000, or 13.8 cents per share, on revenue of $6,438,000 for the comparative...

Continue reading

Ibotta Announces $100 Million Share Repurchase Program

DENVER, Aug. 22, 2024 (GLOBE NEWSWIRE) — Ibotta, Inc. (NYSE: IBTA), the leading technology company providing digital promotions and performance marketing solutions, announced today that its Board of Directors has approved a share repurchase program, with authorization to purchase up to an aggregate of $100 million of the Company’s Class A common stock (the “Share Repurchase Program”). The Share Repurchase Program has no expiration date. Repurchases under the Share Repurchase Program may be made from time to time through open market repurchases or through privately negotiated transactions subject to market conditions, applicable legal requirements, and other relevant factors. Open market repurchases may be structured to occur in accordance with the requirements of Rule 10b-18 under the Securities Exchange Act of 1934, as amended...

Continue reading

NKGen Biotech Receives Notification From Nasdaq Related to Delayed Quarterly Report

SANTA ANA, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) — NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), today announced it received a standard notice (the “Notice”) on August 20, 2024 from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”) because it had not timely filed its Quarterly Report on Form 10-Q for the period ended June 30, 2024 (the “Form 10-Q”) with the Securities and Exchange Commission (the “SEC”) on or before August 19, 2024, the extended period provided for the filing under Rule 12b-25(b) of the Securities Exchange Act of 1934, as amended. The delay is in part due to the recent change in the Company’s independent registered public accounting firm and its valuation firm. The Notice indicated...

Continue reading

Vision Sensing Acquisition Corp. Announces Letter of Intent with Convergence CT, Inc.

Agrees to Terminate Previous Agreement with Mediforum Co., Ltd.Convergence CT, Inc. (“CCT”) is a provider of technologies to manage big data for the benefit of patients, communities, providers, and researchers, and specializes in smart hospital information systems and optimizing hospital workflows, leveraging proprietary technology and customized solutions, integrating IoT and AI to enhance patient care and promote global health insights. Vision Sensing Acquisition Corp. (“VSAC”) is a NASDAQ listed special purpose acquisition company trading under the ticker symbol “VSAC.” VSAC and CCT have agreed to a total consideration to CCT shareholders of US$135 million of which US$110 shall be paid by an initial upfront equity transfer to existing CCT shareholders with the balance subject to an earn-out based on performance.NEW YORK, Aug. 22,...

Continue reading

First Watch Restaurant Group, Inc. Announces Appointment of Charles Jemley and Michael Fleisher to Board of Directors

Leading Daytime Dining concept strengthens Board with appointment of new independent directors BRADENTON, Fla., Aug. 22, 2024 (GLOBE NEWSWIRE) — First Watch Restaurant Group, Inc. (NASDAQ: FWRG) (“First Watch” or the “Company”), the leading Daytime Dining concept serving breakfast, brunch and lunch, today announced the appointment of Charles Jemley to its Board of Directors and as Chair of the Audit Committee effective immediately and the appointment of Michael Fleisher to its Board of Directors effective November 1, 2024. “We are pleased to welcome Charley and Michael to our Board of Directors, and we look forward to leaning on their extensive financial management expertise as we continue to scale the First Watch brand,” said Ralph Alvarez, Chairman of the Board of Directors of First Watch. Jemley’s executive and financial management...

Continue reading

Onex Partners to Invest in Fischbach

All amounts in U.S. dollars unless otherwise stated TORONTO, Aug. 22, 2024 (GLOBE NEWSWIRE) — Onex Corporation (“Onex”) (TSX: ONEX) today announced that Onex Partners Opportunities Fund has agreed to make a majority investment in Fischbach KG (“Fischbach” or the “Company”), the world’s largest provider of cartridge packaging solutions for sealants and adhesives used in building repair, renovation, & construction, aftermarket automotive, marine weather & water-sealing applications, and aerospace bonding applications. The investment has been made alongside the existing owner-management group, led by Managing Directors Thomas Langensiepen and Achim Helmenstein. Financial terms were not disclosed. Headquartered in Engelskirchen, Germany, Fischbach provides full system solutions including plastic cartridges, associated plungers...

Continue reading

SI-BONE To Present at Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024

SANTA CLARA, Calif., Aug. 22, 2024 (GLOBE NEWSWIRE) — SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming Morgan Stanley 22nd Annual Global Healthcare Conference in New York. Management will be hosting a fireside chat on Wednesday, September 4, 2024, at 10:45 a.m. Eastern Time / 7:45 a.m. Pacific Time. Investors interested in listening to the conference call may do so by registering at this link: https://url.us.m.mimecastprotect.com/s/r-x6CjRnDNsnPR3wF7sxumTszz?domain=cc.webcasts.com. Live audio of the webcast will be available on the “Investors” section of the company’s website at: www.si-bone.com. The webcast will be archived and available for replay for at least 90 days after the event. About SI-BONE, Inc. SI-BONE...

Continue reading

Abercrombie & Fitch Co. Announces Election of Andrew Clarke to its Board of Directors

Clarke brings global, executive leadership and a deep connection to consumers around the world NEW ALBANY, Ohio, Aug. 22, 2024 (GLOBE NEWSWIRE) — Abercrombie & Fitch Co. (NYSE: ANF), a leading, global omnichannel specialty retailer of apparel and accessories, today announced the election of Andrew Clarke to its Board of Directors, effective August 21, 2024. Mr. Clarke, 51, is the Global President of Mars Snacking, a division of Mars, Incorporated. In this role, which he has held since 2018, Clarke is responsible for overseeing one of the world’s most iconic portfolio of snack brands, which represents a significant portion of Mars’ total business. He has more than 30 years in consumer-focused industries, with the last 24 years at Mars in roles of increasing responsibility. Clarke started with Mars in UK sales, before moving...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.